Molecular pathways in cerebral ischemia: cues to novel therapeutic strategies
- PMID: 12668901
- DOI: 10.1385/MN:27:1:33
Molecular pathways in cerebral ischemia: cues to novel therapeutic strategies
Abstract
Stroke is one of the leading causes of death and severe disability in most industrialized countries. Despite the extensive research efforts of both academic and industrial laboratories during the last few decades, no changes have been brought about by the design of neuroprotective therapies. The progressive decrease of stroke-induced death and disability is entirely attributable to improvements in the identification and reduction of risk factors. Over the past few years, experimental research has led to the emergence of a wealth of information regarding the complex and interrelated processes of neuronal degeneration and death triggered by ischemia. This unprecedented insight has led to new theories on the mechanisms of ischemic damage, and has suggested new targets and strategies for therapeutic intervention designed to reduce the clinical consequences of stroke. Among current developments, three strategies seem particularly appealing namely, the limitation of initial or secondary neuronal death by inhibition of apoptotic mechanisms, the enhancement of the endogenous capacity of nervous structures to restore lost function, and the replacement of lost cells by transplantation therapy.
Similar articles
-
Apoptosis and Acute Brain Ischemia in Ischemic Stroke.Curr Vasc Pharmacol. 2017;15(2):115-122. doi: 10.2174/1570161115666161104095522. Curr Vasc Pharmacol. 2017. PMID: 27823556 Review.
-
Ischemia and stroke.Adv Exp Med Biol. 2002;513:455-73. doi: 10.1007/978-1-4615-0123-7_17. Adv Exp Med Biol. 2002. PMID: 12575832 Review.
-
[Neuronal apoptosis following cerebral ischemia. Basis, physiopathology and treatment strategies].Anaesthesist. 2001 Dec;50(12):905-20. doi: 10.1007/s00101-001-0247-8. Anaesthesist. 2001. PMID: 11824074 Review. German.
-
[Animal models of cerebral ischemia--testing therapeutic strategies in vivo].Ideggyogy Sz. 2007 Sep 30;60(9-10):356-69. Ideggyogy Sz. 2007. PMID: 17987730 Review. Hungarian.
-
The mechanisms of cell death in focal cerebral ischemia highlight neuroprotective perspectives by anti-caspase therapy.Biochem Pharmacol. 2003 Oct 15;66(8):1643-9. doi: 10.1016/s0006-2952(03)00538-0. Biochem Pharmacol. 2003. PMID: 14555245
Cited by
-
Altered responsiveness of the guinea-pig isolated ileum to smooth muscle stimulants and to electrical stimulation after in situ ischemia.Br J Pharmacol. 2006 Feb;147(4):371-8. doi: 10.1038/sj.bjp.0706618. Br J Pharmacol. 2006. PMID: 16341232 Free PMC article.
-
Imidazol-1-ylethylindazole voltage-gated sodium channel ligands are neuroprotective during optic neuritis in a mouse model of multiple sclerosis.J Med Chem. 2014 Apr 10;57(7):2942-52. doi: 10.1021/jm401881q. Epub 2014 Mar 21. J Med Chem. 2014. PMID: 24601592 Free PMC article.
-
Therapeutic Potential of Pretreatment with Allograft Sertoli Cells Transplantation in Brain Ischemia by Improving Oxidative Defenses.J Mol Neurosci. 2018 Apr;64(4):533-542. doi: 10.1007/s12031-018-1054-x. Epub 2018 Mar 17. J Mol Neurosci. 2018. PMID: 29550901
-
The design of clinical trials for cell transplantation into the central nervous system.NeuroRx. 2004 Oct;1(4):492-9. doi: 10.1602/neurorx.1.4.492. NeuroRx. 2004. PMID: 15717050 Free PMC article. Review. No abstract available.
-
Therapeutic targets for neuroprotection in acute ischemic stroke: lost in translation?Antioxid Redox Signal. 2011 May 15;14(10):1841-51. doi: 10.1089/ars.2010.3292. Epub 2010 Oct 25. Antioxid Redox Signal. 2011. PMID: 20626319 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous